Paxman AB PXMBF
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- $2.80
- Day Range
- $2.80–2.80
- 52-Week Range
- $2.80–7.15
- Bid/Ask
- $6.03 / —
- Market Cap
- $53.24 Mil
- Volume/Avg
- 2,600 / 1,350
Key Statistics
- Price/Earnings (Normalized)
- 1,491.27
- Price/Sales
- 2.91
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Paxman AB is a Sweden based company engages in the development of PAXMAN Scalp Cooling System that is used to minimize hair loss in connection with chemotherapy treatment. The company offers a stand-alone, mobile electric cooling unit, which is a liquid-based cooling system that cools down the patient's scalp through the silicone hat. Geographically the company markets its product to Great Britain, Scandinavian countries, the Netherlands, Belgium, and Australia.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Growth
- Total Number of Employees
- 91
- Website
- https://www.paxman.se
Comparables
Valuation
|
Metric
|
PXMBF
|
OX2
|
ORES
|
|---|---|---|---|
Price/Earnings (Normalized) | 1,491.27 | 12.33 | 18.84 |
Price/Book Value | 4.68 | 2.36 | 1.01 |
Price/Sales | 2.91 | 1.48 | 16.02 |
Price/Cash Flow | 72.43 | 70.74 | 29.08 |
Price/Earnings
PXMBF
OX2
ORES
Financial Strength
|
Metric
|
PXMBF
|
OX2
|
ORES
|
|---|---|---|---|
Quick Ratio | 1.34 | 1.35 | — |
Current Ratio | 1.77 | 2.38 | — |
Interest Coverage | 1.16 | 278.00 | — |
Quick Ratio
PXMBF
OX2
ORES
Profitability
|
Metric
|
PXMBF
|
OX2
|
ORES
|
|---|---|---|---|
Return on Assets (Normalized) | 0.35% | 11.76% | 5.29% |
Return on Equity (Normalized) | 0.51% | 20.69% | 5.40% |
Return on Invested Capital (Normalized) | 8.89% | 17.56% | — |
Return on Assets
PXMBF
OX2
ORES
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Ngvclbzgs | Mhnplm | $184.2 Bil | |
SYK
| Stryker Corp | Yxyrzdpdd | Rff | $125.1 Bil | |
MDT
| Medtronic PLC | Xrxskhyw | Gvdkzjx | $108.5 Bil | |
BSX
| Boston Scientific Corp | Pbbgjxmf | Zsxyntb | $107.1 Bil | |
EW
| Edwards Lifesciences Corp | Rvnksbmtm | Gmwcdn | $51.4 Bil | |
DXCM
| DexCom Inc | Pvwmvvtq | Hyvn | $50.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Pctwqmzv | Jzwz | $25.0 Bil | |
PHG
| Koninklijke Philips NV ADR | Glmxyfhj | Ftbqf | $24.4 Bil | |
ALGN
| Align Technology Inc | Kkqvxhxtp | Ggyqrz | $21.7 Bil | |
PODD
| Insulet Corp | Wzpdlqrsz | Mfcwm | $12.2 Bil |